In this study, we have evaluated the capacity of recombimorphological profiles of transduced cells were consistnant adeno-associated virus (rAAV) vectors, containing cell ently neuronal, and there was no evidence of transgene type-specific promoters, to transduce neurons in vivo in the expression in glial elements. Transduction efficiencies for normal adult rat spinal cord. The neuron-specific enolase the NSE and PDGF rAAVs were estimated at 15 and 45 (NSE) promoter and the platelet-derived growth factor infectious particles per GFP-positive neuron, respectively, (PDGF) B-chain promoter were used to direct expression in the absence of detectable adenovirus. This study of a 'humanized' form of the gene for green fluorescent strongly supports a role for rAAV vectors in CNS gene therprotein (GFP). Neuron-specific rAAVs were injected into apy and lays the groundwork for delivery of more functional the mid-cervical regions of adult rat spinal cords. At genes to spinal cord neurons as a possible way to enhance 10-14 days, expression was detected in all animals and spinal cord repair following injury. persisted for up to 15 weeks. Immunocytochemical and
Introduction
these vectors produce proteins that are either potentially A growing body of evidence is emerging suggesting that cytotoxic or capable of triggering an immune response functional improvement in the injured spinal cord may that, in turn, leads to the demise of infected neurons and be accomplished with a variety of therapeutic strategies.
glia. 15, 16 Additionally, some of these vectors are noninteIn vivo gene delivery offers a viable possibility. The grating and express transgenes only transiently, thereby present investigation, therefore, examined the potential limiting their usefulness for long-term replacement of for driving transgene expression via putative neuron-spespecific gene products. 17 cific promoters in the adult spinal cord in anticipation of We and others have shown that recombinant adenoeventually delivering functional genes to participate in associated virus (rAAV) vectors can transduce neurons, tissue repair and regeneration or neuroplasticity followlung epithelial cells, and retinal cells in vivo and that ing spinal trauma.
rAAV may have some advantages over other systems It is well recognized that the CNS presents unique chalcurrently being used to deliver transgenes to the CNS. [18] [19] [20] [21] [22] lenges as an environment for therapeutic gene delivery. The major advantages are that AAV vectors are capable Retroviruses, which have been used successfully to transof transducing and eliciting long-term stable expression duce proliferating cell populations, are historically ineffrom postmitotic cells and produce little inflammatory fective for introducing genes into the mitotically quiescresponse. [18] [19] [20] [21] 23 ent milieu of the CNS. 1,2 However, a recently described Most previous studies have used the viral CMV proretroviral vector system, based on the human immunomoter to drive foreign gene expression in neurons with deficiency virus, was shown to be capable of stable gene differential patterns of expression occurring in a sitetransfer to CNS neurons in vivo in adult rats. 3 Other labspecific manner in the CNS. 23 To determine if cell typeoratories have demonstrated the basic feasibility of theraspecific promoters would be useful in facilitating transpeutic gene delivery to peripheral and central neurons gene expression, we investigated the capacity of two with herpes simplex virus-type 1 (HSV-1) and adenovirus putative neuron-specific promoters, the neuron-specific vectors.
To solve this problem, we used the gene for the green Transgene expression fluorescent protein (GFP) in the present study as an index For each rAAV preparation used in these experiments, of transgene expression. The studies described below nine adult rats received 5 l injections of virus into the were thus designed to address the following issues perticervical spinal cord enlargement. The animals were then nent to the eventual application of in vivo gene delivery killed at different intervals ranging from 10 days to 15 to the traumatized CNS, in general, and injured spinal weeks after gene delivery. Viral titers for the rAAV prepcord, specifically: (1) efficiency of transduction; (2) durarations ranged between 1.4 × 10 6 -6 × 10 8 infectious paration of transgene expression; (3) transgene expression ticles per millilitre as determined by infectious center relative to the cell type-specific promoters employed; and assay (see Materials and methods). No adenovirus con-(4) the usefulness of the GFP marker for gene therapy tamination was detected in the rAAV stocks by plaque studies. Parts of these results have been previously sumassay. The limit of sensitivity for our plaque assay was marized.
18,19
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2 plaque forming units per millilitre. Therefore, a typical rAAV injection of 5 l contained 10 6 -10 8 rAAV units and less than 0.5 adenovirus plaque forming units.
Results
GFP expression was seen in all animals, and the intensity of expression correlated with titer. Thus, higher titer Vector constructs injections generated positive cells that were readily visThe two neuron-specific vectors used in this study, as ible by routine fluorescence microscopy without well as the parent vector from which they were derived, additional immunostaining, whereas immunocytochemare illustrated in Figure 1 . The construction of the parent ical techniques were required for reporter gene detection vector has been previously documented in detail. 22 Each in tissue specimens from animals receiving lower titer of these vectors contains a 'humanized' version of the gfp virus injections. Irrespective of titer, no overt evidence of gene in which 88 codons have been altered to more cytopathology was seen in transgene-expressing neurons. closely mimic mammalian codon usage. These mutations Long-term expression was observed in normal appearing have served to enhance expression of this protein in neurons with no indication of existing or incipient patholmammalian systems.
22 Also included is the gene conferogy. No surrounding inflammatory responses were indiring neomycin resistance under the control of the HSV cated in any of the specimens examined. thymidine kinase (TK) promoter with polyoma enhancer.
In longitudinal sections, the vast majority of GFP-posiThe AAV 145 bp terminal repeats flanking these genes tive cell bodies were found within 5 mm rostral and cauare the only viral sequences required for packaging the dal to the site of rAAV delivery; some cells in which GFP rAAV vectors and facilitating their integration into the was detected also were present at greater distances. The host genome.
24, 25 The entire cassette has been placed into majority of GFP-expressing cells, however, were seen at a pBlueScript backbone. The neuron-specific vectors were the site of injection, where they were dispersed throughconstructed by replacing the CMV promoter with either the NSE or the PDGF B-chain promoter fragment.
out the gray matter. Interestingly, further away from the Figure 1 The construction of pTRUF2, containing a humanized version of the gene for GFP, has been previously described. 22 1&2 , polyadenylation signals injection site, the distribution of GFP-positive profiles interval. Transduction efficiencies were estimated based on extrapolations from those counts ( Table 1 ). The NSE was predominantly seen at the interface between white and gray matter so that the incidence of transgene virus, at an estimated rAAV titer of 8 × 10 6 /ml, generated one GFP-positive neuron per approximately 15 infectious expressing cells was greater at the margin of gray matter as opposed to more interior regions of the spinal parenparticles ( Figure 5a ). The PDGF virus, at the same titer, yielded one GFP-positive neuron per 45 infectious parchyma. GFP-positive fibers were also present in the lateral and medial white matter tracts. In the dorsal-venticles based on titers generated by infectious center assays ( Figure 5b ). tral plane, GFP-expressing cells were found over a 0.3-1.0 mm range.
Semi-quantitative evaluation of transgene expression Cell type-specific expression
In the absence of antibody labelling, expression was variAll GFP-positive cells had a neuronal morphology with able in both the number of positive cells and degrees of long processes extending from the cell body ( Figure 2) . fluorescence intensity that were observed. In excess of To identify the phenotype of these cells more definitively, 300 GFP-positive cells were counted in one 2.5 cm long tissue sections were labelled with primary monoclonal × 40 m thick slice, with a typical section of that thickness antibodies to either neurofilament (NFM) or glial fibrilcontaining from 10-50 GFP-positive cells. Subsequent lary acidic protein (GFAP), as well as the GFP polyclonal immunocytochemical analyses of tissue, using GFP polyantibody. Immunocytochemical labelling with anti-GFAP clonal antibody, suggested that early counts, noted did not result in any colocalization of GFP ( Figure 3) . above, may have been underestimated by a factor of 10-Conversely, double-labelling with the NFM antibody 50. Much of the fluorescence was undetected at magnifiresulted in co-expression with GFP in many cells cations lower than ×200, and fluorescence was often visu-( Figure 4 ), as did subsequent in vivo double-labelling ally detectable at levels that were not photographically with the retrograde tracer, FluoroGold (FluoroChrome, suitable. Keeping the tissue hydrated gave maximal fluEnglewood, CO, USA) (not shown), which provided orescence, but detection of the protein was attenuated another index of the neuronal character of the GFPupon application of aqueous mounting medium followed expressing cells.
by coverslipping. Without hydration, detection of up to approximately 80% of the positive cells was not possible Transduction efficiency in many cases. Nonetheless, tissue that had been fixed, To obtain an approximation of transduction efficiencies, sliced, and mounted on slides without coverslips for GFP-positive cells were counted in every third antibodyseveral weeks continued to show positive GFP expression labelled 40 m section from a representative animal of after rehydration, although some loss of original signal the NSE and PDGF groups at the 2-month post-injection was noted.
Duration of transgene expression
Long-term studies are currently being undertaken to assess the stability of foreign gene expression in the brain and spinal cord. The longest time-points that we have inspected thus far have been at 8 and 15 weeks after injection. No appreciable increase in the number of GFP-positive cell bodies was evidenced at these times; however, it appeared that many more positively labelled fibers were present in the lateral and medial white matter tracts and the intensity of fluorescence in cell bodies and in fiber tracts seemed to be enhanced. At 15 weeks, GFP-positive fibers could be traced up to the base of the pons rostrally and at least to the thoracic cord caudally. Transgenecontaining fibers were predominantly ipsilateral to the site of injection, although a contralateral distribution of such fibers was not uncommon throughout the sections.
Discussion
The results of this investigation show a high incidence of transgene expression in neurons of the adult mammalian spinal cord following injection of rAAV constructs employing cell type-specific promoters. The findings also demonstrate substantial levels of transduction efficiency for at least as long as 3 months after in vivo transgene delivery. This study has also explored the feasibility of GFP as a reporter gene and whether its unique attributes can be exploited for studies of in vivo gene delivery in 
Figure 3 GFP-positive neurons under the control of the NSE promoter 2 months after injection with rAAV. Tissue double-labelled with the polyclonal antibody against GFP (a) as well as a monoclonal GFAP antibody (b) showed no colocalization of the two proteins (c). Double-labelling with the polyclonal GFP antibody (d) and a monoclonal neurofilament antibody (e) showed cells co-expressing both proteins (f)
Cell type-specific promoters of transgene expression in neurons based on cellular morOur previous studies (unpublished results) examined the phology and double immunolabelling. No GFP colocalizuse of the CMV viral promoter to drive transgene ation was observed in GFAP-immunostained cells and, expression in the spinal cord, as well as in cell cultures.
given the cell diameters and geometry of GFP-positive Neuronal expression was predominant, as observed by profiles, no suggestion of oligodendrocyte expression others, but did not preclude detection in astrocytes, was obtained warranting further immunocytochemical macrophages, and endothelial cells. 20, 23, 26 Furthermore, analysis. On the other hand, NFM antibody staining detransgene expression using vectors containing the viral monstrated colocalization with GFP. In contrast, a CMV promoter was relatively low with fewer than 50 recently constructed vector in which GFP is driven by the total GFP-positive neurons in each of four animals astrocyte-specific GFAP promoter is capable of generatinjected with 5 l of a 10 7 -10 8 virus stock. Based on that ing substantial transgene expression in astrocytes. These initial experience, it was of interest to test whether cellinitial findings suggest that the GFAP rAAV is capable type specific promoters could improve the specificity and of transducing astrocytes under appropriate conditions frequency of cellular transgene expression.
and more intensive investigation of this construct is in Because NSE is one of the most abundant brain-specific progress. We also noted in the present study a differential proteins and mRNAs in the adult mammalian CNS, we degree of GFP expression relative to the NSE and PDGF elected to examine the ability of the NSE promoter to promoters (Table 1) such that a three-fold increase in drive transgene expression in an AAV delivery system. 27 GFP-positive neurons was seen with injections of the NSE This promoter has been used to facilitate neuron-specific rAAV. This could reflect variability in the regulation of expression of ␤-galactosidase both in transgenic mice and these promoters with regard to the metabolic state of the in an in vivo herpes gene delivery system. 28, 29 We also tissue, as suggested by other published findings. 23 It is examined the effectiveness of the PDGF promoter, since important to emphasize, however, that the present data PDGF expression has been found in all areas of the CNS, do not permit any conclusions to be drawn regarding the and its characterization has shown expression of the Brelative efficacy of either promoter. Rather, the results chain protein to be limited to neurons. Furthermore, neuprovide a basic indication of the propensity of rAAV to ronally restricted expression by the B-chain promoter has effectively and efficiently transduce neurons. Long-term been confirmed through the generation of transgenic quantitative studies are in progress to statistically investimice. 30, 31 gate the efficacy and persistence across promoters. Our findings show a remarkably exclusive localization
Figure 4 Two months after injection of the PDGF rAAV, tissue was processed with the polyclonal GFP antibody (top left) and a monoclonal antibody against GFAP (b). Consistent with the NSE injections, no colocalization of GFP and GFAP was seen (c), whereas staining for polyclonal GFP (bottom left) and monoclonal neurofilament (e) antibodies resulted in co-expression of these two proteins (f)
Transduction efficiency
The transduction efficiencies generated by these data are encouraging. Up to one transduced cell was seen per 15 obtained by the single cell fluorescence assay were con-48-57 0 0 sistently higher by a factor of 5. In the current study, underestimations by a factor of 10-100 would still gener- Green fluorescent protein Traditionally, the E. coli lacZ gene coding for ␤-galactosidase has been used as a benign marker to demonstrate the successful introduction of a foreign gene. The size of down in gene expression had occurred and supports the feasibility of stable, long-term transgene expression in the CNS. Other laboratories, using ␤-galactosidase as a reporter gene under the control of a viral promoter (CMV), have shown site-specific variability in the duration of transgene expression in the forebrain. 23 Although the possibility remains that certain neuronal cell populations within the spinal cord may differ, no overall loss of signal was evidenced for at least 2 months with either promoter and for up to 3. months for the PDGF construct (the NSE rAAV has not yet been examined at this timepoint). This longevity of transgene expression also argues against overt neurotoxicity, and in that context, our findings are consistent with other reports showing an absence of cellular necrosis and inflammation in regions of AAV injection.
20,23
Distribution of GFP-positive neurons and axons The majority of neurons expressing GFP were located at the site of injection; however, it was of considerable interest to see GFP-positive cells at more distant rostral and caudal levels. It is unlikely that this could be due to uptake and retrograde transport of virions based on the number and distribution of more distant neuronal cell bodies. The intriguing distribution of cells at the interface between white and gray matter raises the possibility that an anatomical gradient may exist that favors at least some local diffusion of the injected virus from the site of injection at or near the interface between white and gray matter. These findings may prove useful when defining parameters for the introduction of trophic and/or tropic cell's cytoplasm and its processes, this alone may account for intra-axonal detection of GFP. However, the possithe lacZ gene (approximately 3.5 kb) makes this a less bility cannot be totally excluded that at least some of the attractive choice for AAV vectors even when smaller viral detected GFP could be related to anterograde transport promoters are employed. Therefore, we investigated the of the protein. gfp gene which is responsible for the bioluminescence of
In conclusion, these observations collectively demonthe jellyfish Aequorea victoria. 36 As previously stated, strate fundamental dynamics and parameters associated mutations have since been made to this gene to enhance with in vivo gene delivery to the adult spinal cord. The its expression in mammalian systems. 22 GFP is a small investigation and use of cell type-specific promoters, not protein, and its cDNA (approximately 700 bp) fits easily only as a means of therapeutic gene delivery but also as into AAV vectors, and as illustrated by this study, even a tool for examining neurobiological systems, has advanin constructs containing larger, cell-specific promoters.
tages over the use of more general viral promoters. These This characteristic of gfp also presents an option for the and similar constructs can be used to capitalize on the inclusion of additional cDNAs in these vectors.
system's own developmental windows and/or biological One of the more appealing features of GFP is that it processes (eg injury responses) to meet a number of can be visualized under fluorescein optics without the therapeutic needs or answer a wide range of neurobiologaddition of substrates. As found in this study, however, ical questions. Future studies will examine how these the intensity of detected signal can vary depending upon parameters of gene delivery using these and other rAAV biological and technical conditions. Such variation preconstructs are influenced by post-traumatic pathosumably reflects incomplete penetrance of the gfp marker physiological mechanisms. and could influence the reliability of cell counts and phenotypic identification. Our findings indicated, how-
Materials and methods
ever, that GFP signal can be maximally enhanced by employing immunocytochemical procedures. The unamConstruction of vectors biguous demonstration of in vivo foreign gene expression thus lends support for continued use of GFP as a reliable index of transgene delivery.
Neuron-specific enolase promoter NSEEXPI1, provided by G Sutcliffe of the Scripps Clinic (La Jolla, CA, USA), contains the 2.7 kb promoter and intron 1 sequence from Duration of transgene expression Based on the apparent rapidity of GFP turnover in vitro, the rat neuron-specific enolase gene. 28 A BssHII digest and Klenow fill, followed by an XhoI partial digest, genthe long persistence of GFP signal suggests that no shut-erated a 2.2 kb fragment containing 1.8 kb of the propendently, by single cell fluorescence assay (SCFA). rAAV-UF5 carries the double mutant of the GFP reporter moter and a fragment of exon 1 (untranslated leader sequence). This fragment has been shown to have full gene F64L/S65T (the construction to be described elsewhere) under the control of the CMV promoter. The promoter activity.
28 pTRUF2 (Figure 1 ), described previously, contains the gene for 'humanized' GFP under the yield and intensity of the fluorescence of the double mutant is six times higher than of the red-shifted S65T control of the cytomegalovirus (CMV) promoter as well as the gene conferring neomycin resistance driven by the mutant. 38 Assuming, therefore, that the gene penetrance of the F64L/S65T is sufficient to detect one infectious parthymidine kinase promoter and polyoma enhancer.
22
These genes are flanked by the 145 bp terminal repeats ticle per cell, we used the SCFA to compare its efficiency to the ICA. 22, 39 293 Cells in a 96-well dish, plated at a 50% of the adeno-associated virus. This vector was digested with KpnI, blunt-ended with T 4 polymerase, and partially confluency, were infected with serial dilutions of rAAV-UF5 and co-infected with Ad (MOI of 10) to increase the digested with XhoI to remove the CMV promoter segment. The appropriate sized bands were gel-isolated, transduction efficiency of rAAV. Forty hours later cells infected with rAAV-UF5 were visually scored using a excised, and subsequently ligated to generate pTRNSE in which the GFP gene is under the control of the NSE fluorescence microscope and the titer was calculated according to a dilution factor. Under this condition the promoter.
titers obtained by SCFA were consistently higher than those obtained by ICA by a factor of 5. Platelet-derived growth factor promoter: Platelet-derived growth factor promoter was donated by T Collins at HarTo assess for the presence of wild-type adenovirus, HEK 293 cells were exposed to recombinant virus and vard (Boston, MA, USA) and contains the 1.3 kb promoter fragment of the PDGF gene. 31 The plasmid was assessed for cytopathic effects. No cytopathology was evident in cells exposed to any of the heat-inactivated first digested with XbaI, blunt-ended with the Klenow fragment, and ligated to KpnI linkers. The plasmid was viral stocks. Subsequently plaque assays demonstrated that wild-type adenovirus in all viral preparations used then digested with HindIII, partially filled with dATP and dGTP and finally digested with KpnI. pTRUF2, in these studies was undetectable (less than 10 2 p.f.u. per ml). described briefly above, was digested with XbaI, partially filled with dCTP and dTTP, and subsequently digested with KpnI. These procedures generated cohesive ends Animal groups and surgical procedures Adult (250-350 g), female Sprague-Dawley rats (Zivicfrom each plasmid which were subsequently excised from a gel and ligated to generate pTRPDGF, which
Miller, Allison Park, PA, USA) were used in this study. All animal surgical and care procedures were approved places the gene for GFP under the control of the PDGF promoter.
by the Institutional Animal Care and Use Committee at the University of Florida. Anesthesia was induced by subcutaneous injection of xylazine (Ben Venue LaboraProduction of recombinant AAV Human embryonic kidney (HEK) 293 cells were cotranstories, Bedford, OH, USA; 6.7 mg/kg) followed by an intraperitoneal injection of ketamine (Fort Dodge Laborafected with pTRNSE or pTRPDGF and the helper plasmid pIM45 which contains the AAV genome without terminal tories, Fort Dodge, IA, USA; 90 mg/kg). Under aseptic conditions, the skin on the dorsal surface of the neck was repeats. 37 The cells were subsequently infected with adenovirus at a multiplicity of infection of 10. On the incised and the musculature overlying the C 4 vertebra retracted. A laminectomy was performed on the C 4 verthird day following infection cells were harvested and subjected to three successive freeze/thaw cycles. Viral tebra using Rongeur forceps. One to two drops of lidocaine were placed on the exposed dura and allowed to stocks were then heated to 56°C for 30 min to inactivate wild-type adenovirus. Recombinant AAV was collected remain for approximately 1 min before removal with a cotton swab. The dura over the dorsal root entry zone by purifying the viral stock through a CsCl gradient (1.40 g/ml) formed in a SW41 rotor for 48 h at 200 000 g.
was unilaterally incised with a microscalpel. Using a micromanipulator, a 30-gauge needle Hamilton syringe A series of 600 l fractions were collected from the gradient and probed for the presence of rAAV using a 32 Pwas lowered to the exposed surface of the spinal cord and then carefully inserted to a depth of 2.0 mm. Five labelled probe to the gfp gene. Positive fractions were precipitated with polyethylene glycol (PEG) 8000 and resusmicroliters of the relevant vector were slowly injected over an approximately 2 min interval in 0.5 l pulses. pended in a 50 mm Tris (pH 8.4)/25 mm EDTA buffer.
Following the injection procedure, the overlying musculature was sutured in layers and the skin closed with surInfectious center assay rAAV was titrated by the infectious center assay (ICA) gical wound clips. A total of nine animals were injected with each of the neuronal promoter rAAV constructs and essentially as described. 25 293 Cells were infected with serial dilutions of rAAV. Infectious particles were amplifour animals with the CMV vector. Similar anesthetics and surgical procedures were used to inject 0.25 l of fied by infection with Ad and wild-type (wt) AAV helpers at an MOI of 10 and 4, respectively. The cells were FluoroGold (FluoroChrome) into the C 8 /T 1 spinal levels of one rat from each condition 3 days before killing the incubated for 24 h, harvested, transferred to a nylon membrane, and lysed by NaOH treatment. The viral animals. Tissue was subsequently examined with fluorescence microscopy to confirm colocalization with GFP. DNA attached to the filter was hybridized to a 32 P-labelled probe for gfp. Viral titers for recombinant AAV ranged between 1.4 × 10 6 -6 × 10 8 infectious particles per Immunohistochemistry Animals were anesthetized with 100 mg/kg sodium millilitre.
To determine the accuracy factor of an ICA we compentobarbital i.p. and perfused with a 0.9% saline solution followed by cold 4% paraformaldehyde. The spinal pared the titer of rAAV-UF-5, obtained by ICA and, inde-
